Your browser doesn't support javascript.
loading
Evaluation of miR-21 and miR-375 as prognostic biomarkers in esophageal cancer.
Winther, Mette; Alsner, Jan; Tramm, Trine; Baeksgaard, Lene; Holtved, Eva; Nordsmark, Marianne.
Afiliación
  • Winther M; a Department of Experimental Clinical Oncology , Aarhus University Hospital , Aarhus , Denmark.
  • Alsner J; a Department of Experimental Clinical Oncology , Aarhus University Hospital , Aarhus , Denmark.
  • Tramm T; b Department of Pathology , Aarhus University Hospital , Aarhus , Denmark.
  • Baeksgaard L; c Department of Oncology , Rigshospitalet , Copenhagen , Denmark.
  • Holtved E; d Department of Oncology , Odense University Hospital , Odense , Denmark.
  • Nordsmark M; e Department of Oncology , Aarhus University Hospital , Aarhus , Denmark.
Acta Oncol ; 54(9): 1582-91, 2015.
Article en En | MEDLINE | ID: mdl-26481465
ABSTRACT

BACKGROUND:

MicroRNAs (miRNAs) have been associated with prognosis in esophageal cancer, suggesting a role for miRNAs to help guide treatment decisions. Especially, miR-21 and miR-375 have been investigated as prognostic biomarkers. The aim of this study was to evaluate the prognostic potential of miR-21 and miR-375 in primary esophageal squamous cell carcinomas (ESCC) and esophagogastric adenocarcinomas (EAC). MATERIAL AND

METHODS:

Pre-therapeutic tumor specimens from 195 patients with loco-regional esophageal cancer treated with neoadjuvant or definitive chemoradiotherapy or perioperative chemotherapy were analyzed. Expression levels of miR-21 and miR-375 were quantified using Affymetrix GeneChip miRNA 1.0 Array. The Cox proportional hazards model was used to assess the correlation of miR-21 and miR-375 with disease-specific survival (DSS) and overall survival (OS). Forest plots were performed to evaluate the prognostic impact of miR-21 and miR-375 in the present study and previously published reports.

RESULTS:

In ESCC, patients with miR-21 expression levels above median showed a trend towards poorer DSS and OS. When dividing miR-21 expression by tertiles, high levels of miR-21 significantly correlated with shortened DSS [HR 1.76 (95% CI 1.05-2.97) but not OS. Similarly for EAC, a significant association between miR-21 expression above median and DSS was observed [HR 3.37 (95% CI 1.41-8.05)], in addition to a trend towards poorer OS for patients with miR-21 expression above median. Multivariate analyses identified miR-21 as an independent prognostic marker for DSS in EAC [HR 3.52 (95% CI 1.06-11.69)]. High miR-375 was not correlated with improved prognosis in either histology. However, Forest plots demonstrated that both miR-21 and miR-375 were of prognostic impact in ESCC.

CONCLUSION:

In this study, miR-21 was identified as an independent prognostic biomarker for DSS in patients with EAC whereas miR-21 failed to show independent prognostic significance in ESCC. High miR-375 was not associated with enhanced survival in either histology.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas / Adenocarcinoma / Biomarcadores de Tumor / MicroARNs Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Acta Oncol Asunto de la revista: NEOPLASIAS Año: 2015 Tipo del documento: Article País de afiliación: Dinamarca

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas / Adenocarcinoma / Biomarcadores de Tumor / MicroARNs Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Acta Oncol Asunto de la revista: NEOPLASIAS Año: 2015 Tipo del documento: Article País de afiliación: Dinamarca